Trials that use: Covariate adjustment
4,539 results
- Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328): Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence of Nomegestrol Acetate (NOMAC) and Estradiol (E2) in Commercial Versus Phase 3 Pivotal Clinical Batches of NOMAC-E2 Tablets (P06328): primary endpoint results, effect estimate with confidence interval,…
- Bioequivalence of Two Different Capsule Types of Dabigatran: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence of Two Different Capsule Types of Dabigatran: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01290757).
- Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A): Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face: Complete Statistical AnalysisIndependent statistical analysis of Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- BIOGUIDE-XIndependent statistical analysis of Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Biomarkers in First Episode Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Biomarkers in First Episode Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02033382).
- Biomechanical Validation of the Transfer Assessment Instrument (TAI): Complete Statistical AnalysisIndependent statistical analysis of Biomechanical Validation of the Transfer Assessment Instrument (TAI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183546).
- BK Treatment Study: Complete Statistical AnalysisIndependent statistical analysis of BK Treatment Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01034176).
- BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults: Complete Statistical AnalysisIndependent statistical analysis of BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts: Complete Statistical AnalysisIndependent statistical analysis of Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BLIR-HIVIndependent statistical analysis of Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01228318).
- BLISS4Independent statistical analysis of Effect of Deep Versus Moderate Neuromuscular Block During Sevoflurane Anesthesia on Intraoperative Surgical Conditions.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BLOCk-CTIIndependent statistical analysis of Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Blueberry Consumption and Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Blueberry Consumption and Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02972996).
- BLUESIndependent statistical analysis of Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05026710).
- BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study): Complete Statistical AnalysisIndependent statistical analysis of BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Body Weight, Sleep, and Heart Health: Complete Statistical AnalysisIndependent statistical analysis of Body Weight, Sleep, and Heart Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388788).
- BODY-REALIndependent statistical analysis of Clinical Effectiveness of Body Fat Distribution Imaging in Real-World Practice: The BODY-REAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BOLTIndependent statistical analysis of A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen: Complete Statistical AnalysisIndependent statistical analysis of Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen: primary endpoint results, effect estimate…
- Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Bone Wax Use for Hemostasis During Primary Unilateral Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BOOST™Independent statistical analysis of Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- BOREASAn independent statistical analysis of the phase 3 BOREAS trial of dupilumab versus placebo in COPD with type 2 inflammation, covering the negative binomial exacerbation analysis, MMRM lung-function and symptom endpoints, logistic…
- BOREASIndependent statistical analysis of Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders: Complete Statistical AnalysisIndependent statistical analysis of Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00869323).
- Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence…
- Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis: Complete Statistical AnalysisIndependent statistical analysis of Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis:…
- BOSTON-4Independent statistical analysis of A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Botox + FESIndependent statistical analysis of Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- BOTOX® Economic Spasticity Trial (BEST): Complete Statistical AnalysisIndependent statistical analysis of BOTOX® Economic Spasticity Trial (BEST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549783).
- BOTOX® for the Treatment of Platysma Prominence: Complete Statistical AnalysisIndependent statistical analysis of BOTOX® for the Treatment of Platysma Prominence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03915067).
- BOTOX® Prophylaxis in Patients With Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of BOTOX® Prophylaxis in Patients With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01432379).
- BotticelliIndependent statistical analysis of Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Botulinum Toxin A to Treat Arm Tremor: Complete Statistical AnalysisIndependent statistical analysis of Botulinum Toxin A to Treat Arm Tremor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02207946).
- Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness: Complete Statistical AnalysisIndependent statistical analysis of Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia: Complete Statistical AnalysisIndependent statistical analysis of Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BP MAPIndependent statistical analysis of Improving BP Control in Diverse Populations Using BP MAP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03818659).
- Brain Stimulation and Enhancing Cognition in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Brain Stimulation and Enhancing Cognition in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03653351).
- Brain Training to Enhance Frontal Lobe Reasoning: Complete Statistical AnalysisIndependent statistical analysis of Brain Training to Enhance Frontal Lobe Reasoning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01552473).
- BRAiN-MIndependent statistical analysis of Bringing Relief to Adolescents Naturally Using Melatonin for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02344316).
- BRAVE-EPAIndependent statistical analysis of Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02719327).